Gabalex Capital Management’s Amgen AMGN Stock Holding History

Gabalex Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,000	Closed	-$7.63M	–	23
2020 Q3	$7.63M	Buy	30,000 +10,000	+50%	+$2.48M	2.13%	19
2020 Q2	$4.72M	Hold	20,000	–	–	1.49%	21
2020 Q1	$4.05M	Hold	20,000	–	–	1.4%	20
2019 Q4	$4.82M	Hold	20,000	–	–	1.26%	20
2019 Q3	$3.87M	Hold	20,000	–	–	1.04%	23
2019 Q2	$3.69M	Hold	20,000	–	–	0.96%	23
2019 Q1	$3.8M	Buy	+20,000	New	+$3.82M	1.1%	22

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gabalex Capital Management's AMGN Position: Q4 2020 in Review

Gabalex Capital Management sold out of Amgen (AMGN) in Q4 2020, closing a stake of 30,000 shares — an estimated $7.63M sold.

Gabalex Capital Management first reported a position in AMGN in Q1 2019 and held it in 7 quarters. The position peaked at $7.63M in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Gabalex Capital Management reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Gabalex Capital Management sold 30,000 Amgen shares in Q4 2020, an estimated $7.63M.
Gabalex Capital Management first reported a position in Amgen in Q1 2019 and held it in 7 quarters.
Gabalex Capital Management's Amgen position peaked at $7.63M in Q3 2020.
2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Gabalex Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.